{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:27:05Z","timestamp":1781641625042,"version":"3.54.5"},"reference-count":42,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Bayer"},{"name":"the legacy of Armand Mas Viladot"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Prostate cancer with bone metastasis exhibits significant heterogeneity, complicating prognosis, and treatment. This study explores the potential of plasma, serum, and urine biomarkers to stratify patients and evaluate their prognostic value. Using two-step clustering, we analyzed baseline levels of Platelet-derived growth factor-BB (PDGF-BB), Insulin-like growth factor-binding protein 1 (IGFBP-1), Bone Morphogenetic Protein 2 (BMP-2), Vascular endothelial growth factor (VEGF) (plasma and urine), prostate-specific antigen (PSA), neuron-specific enolase (NSE), chromogranin A (CgA) and bone-specific alkaline phosphatase (BAP) (serum) and creatinine (Cr), and type I collagen-cross-linked N telopeptide (NTx) (urine) in 29 patients with prostate cancer and bone metastasis. Longitudinal biomarker dynamics were assessed at baseline, 6 months, and 12 months. Clinical outcomes were evaluated using Kaplan\u2013Meier and multivariate analyses. Three distinct groups (C1, C2, and C3) were identified. C1 exhibited elevated pPDGF-BB and pVEGF levels, C3 had increased pBAP and uNTx\/Cr, and C2 showed lower biomarker levels. Prior treatments influenced biomarker levels, with bisphosphonates reducing bone turnover markers and radiotherapy correlating with long-term changes in growth factors. Longitudinal analysis revealed unique biomarker dynamics within each group, with a tendency for pPDGF-BB and pVEGF levels to decrease over time in C1, and distinct trends in uNTx\/Cr between groups. Despite individual biomarkers failing to predict survival, C3 patients demonstrated significantly worse survival than C1 and C2. Molecular clustering of peripheral blood and urinary biomarkers identifies distinct subgroups with metastatic castration-resistant prostate cancer patients outperforming traditional models in outcome prediction and supporting its potential for personalized treatment and prognosis.<\/jats:p>","DOI":"10.3390\/ijms26104669","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T11:31:49Z","timestamp":1747135909000},"page":"4669","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pilot Investigation on Markers of Bone Metabolism, Angiogenesis, and Neuroendocrine Activity as Potential Predictors of Survival of Metastatic Prostate Cancer Patients with Bone Metastases"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1574-9861","authenticated-orcid":false,"given":"Maria Angels","family":"Ortiz","sequence":"first","affiliation":[{"name":"Inflammatory Diseases, Institut de Recerca Sant Pau (IR SANT PAU), 08041 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6060-1110","authenticated-orcid":false,"given":"Georgia","family":"Anguera","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, 08025 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Cant\u00f3","sequence":"additional","affiliation":[{"name":"Inflammatory Diseases, Institut de Recerca Sant Pau (IR SANT PAU), 08041 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Alejandre","sequence":"additional","affiliation":[{"name":"Inflammatory Diseases, Institut de Recerca Sant Pau (IR SANT PAU), 08041 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"Mora","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, 08025 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2875-4405","authenticated-orcid":false,"given":"Ruben","family":"Osuna-G\u00f3mez","sequence":"additional","affiliation":[{"name":"Inflammatory Diseases, Institut de Recerca Sant Pau (IR SANT PAU), 08041 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3639-3291","authenticated-orcid":false,"given":"Maria","family":"Mulet","sequence":"additional","affiliation":[{"name":"Inflammatory Diseases, Institut de Recerca Sant Pau (IR SANT PAU), 08041 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradip","family":"Mora","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, 08025 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assumpta","family":"Antonijuan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, 08025 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, 08025 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ona","family":"Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, 08025 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Orantes","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, 08025 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Maroto","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, 08025 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3909-6682","authenticated-orcid":false,"given":"Silvia","family":"Vidal","sequence":"additional","affiliation":[{"name":"Inflammatory Diseases, Institut de Recerca Sant Pau (IR SANT PAU), 08041 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of Prostate Cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"17.e9\u201317.e18","DOI":"10.1016\/j.urolonc.2014.09.010","article-title":"The burden of skeletal-related events in patients with prostate cancer and bone metastasis","volume":"33","author":"Roghmann","year":"2015","journal-title":"Urol. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Zhu, S., Chen, J., and Zeng, H. (2023). Our Current Understanding of the Heterogeneity in Prostate Cancer and Renal Cell Carcinoma. J. Clin. Med., 12.","DOI":"10.3390\/jcm12041526"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ying, M., Mao, J., Sheng, L., Wu, H., Bai, G., Zhong, Z., and Pan, Z. (2023). Biomarkers for Prostate Cancer Bone Metastasis Detection and Prediction. J. Pers. Med., 13.","DOI":"10.3390\/jpm13050705"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.eururo.2023.03.036","article-title":"Bone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer: Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with or Without Orteronel","volume":"85","author":"Lara","year":"2024","journal-title":"Eur. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1593\/neo.10610","article-title":"Evolving role of bone biomarkers in castration-resistant prostate cancer","volume":"12","author":"Brown","year":"2010","journal-title":"Neoplasia"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1158\/0008-5472.CAN-04-2033","article-title":"Osteoprotegerin in prostate cancer bone metastasis","volume":"65","author":"Corey","year":"2005","journal-title":"Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF02883737","article-title":"Serum levels of bone alkaline phosphatase in breast and prostate cancers with bone metastasis","volume":"15","author":"Ramaswamy","year":"2000","journal-title":"Indian J. Clin. Biochem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/bjc.2012.345","article-title":"Plasma osteopontin as a biomarker of prostate cancer aggression: Relationship to risk category and treatment response","volume":"107","author":"Thoms","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1054\/bjoc.1999.1012","article-title":"Markers of bone turnover for the management of patients with bone metastases from prostate cancer","volume":"82","author":"Garnero","year":"2000","journal-title":"Br. J. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13550-020-00640-2","article-title":"Neuron-specific enolase has potential value as a biomarker for [(18)F]FDG\/[(68)Ga]Ga-PSMA-11 PET mismatch findings in advanced mCRPC patients","volume":"10","author":"Rosar","year":"2020","journal-title":"EJNMMI Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00345-022-04248-0","article-title":"Chromogranin A: A useful biomarker in castration-resistant prostate cancer","volume":"41","author":"Ploussard","year":"2023","journal-title":"World J. Urol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Guo, Y., Wang, L., Hu, J., Feng, D., and Xu, L. (2018). Diagnostic performance of choline PET\/CT for the detection of bone metastasis in prostate cancer: A systematic review and meta-analysis. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0203400"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.eururo.2014.10.001","article-title":"Bone-related Parameters are the Main Prognostic Factors for Overall Survival in Men with Bone Metastases from Castration-resistant Prostate Cancer","volume":"68","author":"Fizazi","year":"2015","journal-title":"Eur. Urol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.21037\/tau-20-1120","article-title":"Oncological validation of bone turnover markers c-terminal telopeptide of type I collagen (1CTP) and peptides n-terminal propeptide of type I procollagen (P1NP) in patients with prostate cancer and bone metastases","volume":"10","author":"Aufderklamm","year":"2021","journal-title":"Transl. Androl. Urol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e2437871","DOI":"10.1001\/jamanetworkopen.2024.37871","article-title":"Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer","volume":"7","author":"Goldkorn","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1038\/ncomms5684","article-title":"Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs","volume":"5","author":"Enroth","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"127rv123","DOI":"10.1126\/scitranslmed.3003180","article-title":"Beyond PSA: The next generation of prostate cancer biomarkers","volume":"4","author":"Prensner","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ali, H.E.A., Gaballah, M.S.A., Gaballa, R., Mahgoub, S., Hassan, Z.A., Toraih, E.A., Drake, B.F., and Abd Elmageed, Z.Y. (2021). Small Extracellular Vesicle-Derived microRNAs Stratify Prostate Cancer Patients According to Gleason Score, Race and Associate with Survival of African American and Caucasian Men. Cancers, 13.","DOI":"10.3390\/cancers13205236"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.4161\/cbt.6.12.4976","article-title":"PDGF BB induces VEGF secretion in ovarian cancer","volume":"6","author":"Matei","year":"2007","journal-title":"Cancer Biol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"bio036566","DOI":"10.1242\/bio.036566","article-title":"Chromogranin A regulates neuroblastoma proliferation and phenotype","volume":"8","author":"Zhang","year":"2019","journal-title":"Biol. Open"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1464-5491.2004.01200.x","article-title":"Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus","volume":"21","author":"Kim","year":"2004","journal-title":"Diabet. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e28804","DOI":"10.1097\/MD.0000000000028804","article-title":"Serum VEGF-D level is correlated with renal dysfunction and proteinuria in patients with diabetic chronic kidney disease","volume":"101","author":"Nguyen","year":"2022","journal-title":"Medicine"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1158\/1078-0432.CCR-06-0269","article-title":"Markers of bone metabolism and survival in men with hormone-refractory metastatic prostate cancer","volume":"12","author":"Cook","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1172\/JCI114459","article-title":"Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro","volume":"85","author":"Carano","year":"1990","journal-title":"J. Clin. Investig."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","article-title":"Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo","volume":"10","author":"Hughes","year":"1995","journal-title":"J. Bone Miner. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF02555852","article-title":"Inhibition of bone resorption by bisphosphonates: Interactions between bisphosphonates, osteoclasts, and bone","volume":"49","author":"Flanagan","year":"1991","journal-title":"Calcif. Tissue Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bone.2007.03.011","article-title":"Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate","volume":"41","author":"McClung","year":"2007","journal-title":"Bone"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/1759720X12444175","article-title":"The role of bone morphogenetic proteins in ankylosing spondylitis","volume":"4","author":"Carter","year":"2012","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3892\/br.2021.1442","article-title":"Insulin-like growth factor-I and wound healing, a potential answer to non-healing wounds: A systematic review of the literature and future perspectives","volume":"15","author":"Garoufalia","year":"2021","journal-title":"Biomed. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1002\/cam4.871","article-title":"Is there a role for IGF-1 in the development of second primary cancers?","volume":"5","author":"Shanmugalingam","year":"2016","journal-title":"Cancer Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1097\/MD.0000000000000163","article-title":"Effects of abiraterone acetate on chronic kidney disease in 2 patients with metastatic castration-resistant prostate cancer","volume":"93","author":"Francini","year":"2014","journal-title":"Medicine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1001\/jamaoncol.2019.1011","article-title":"Assessment of the Safety of Glucocorticoid Regimens in Combination With Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer: A Randomized, Open-label Phase 2 Study","volume":"5","author":"Attard","year":"2019","journal-title":"JAMA Oncol."},{"key":"ref_34","first-page":"273","article-title":"Neuroendocrine differentiation of prostate cancer: A review","volume":"2","author":"Parimi","year":"2014","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00262-014-1573-4","article-title":"Radiation-induced autophagy potentiates immunotherapy of cancer via up-regulation of mannose 6-phosphate receptor on tumor cells in mice","volume":"63","author":"Kim","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Costa, S., and Reagan, M.R. (2019). Therapeutic Irradiation: Consequences for Bone and Bone Marrow Adipose Tissue. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00587"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-4598-12-7","article-title":"Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site","volume":"12","author":"Eisermann","year":"2013","journal-title":"Mol. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"418340","DOI":"10.1155\/2013\/418340","article-title":"The role of vascular endothelial growth factor in metastatic prostate cancer to the skeleton","volume":"2013","author":"Roberts","year":"2013","journal-title":"Prostate Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/cvr\/cvn258","article-title":"Platelet-derived growth factor BB stimulates vasculogenesis of embryonic stem cell-derived endothelial cells by calcium-mediated generation of reactive oxygen species","volume":"81","author":"Lange","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jnci\/dji002","article-title":"Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors","volume":"97","author":"Brown","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.urolonc.2010.08.007","article-title":"Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer","volume":"30","author":"Saad","year":"2012","journal-title":"Urol. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/sj.bjc.6601437","article-title":"Bone resorption predicts for skeletal complications in metastatic bone disease","volume":"89","author":"Brown","year":"2003","journal-title":"Br. J. Cancer"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/10\/4669\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:32:07Z","timestamp":1760031127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/10\/4669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["ijms26104669"],"URL":"https:\/\/doi.org\/10.3390\/ijms26104669","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]}}}